PEPS Presale Leads a Differing Shortlist of November Crypto Picks
Two outlets highlight PeptideSwap’s marketplace launch, but their wider selections and November framing diverge.
Two outlets highlight PeptideSwap’s marketplace launch, but their wider selections and November framing diverge. Bitcoin (BTC) is trading at ₹71,90,959 ($76,065.00), up 0.7% since this brief published. This is an original Token Times brief based on reporting by CaptainAltcoin, with live market data added, as of Fri, 06 Nov 2026 09:45:01 UTC.
PeptideSwap’s alpha launch puts a new token and peptide-focused marketplace into circulation, while Morpho, Bitcoin and Monero provide broader exposure to established crypto sectors. The differing shortlists show that the feature is being positioned within a much wider month-long market watchlist.
- PeptideSwap launched an alpha marketplace targeting the peptide sector
- CaptainAltcoin cites a $140B peptide-industry opportunity
- Brave New Coin highlights six assets; CaptainAltcoin centers on PEPS
- Bitcoin fell 6.00% over 24 hours as market sentiment turned fearful
CaptainAltcoin spotlighted PeptideSwap, or PEPS, as the leading cryptocurrency in its November selection, citing an alpha release of a planned crypto-friendly marketplace for the peptides industry. The outlet describes the platform as aiming to become the world’s largest marketplace of its kind, links readers to its presale and cites a $140B addressable industry. Those are the outlet’s claims rather than independently verified market-size or ranking data in the supplied coverage.
Brave New Coin took a broader approach. Its November 2026 shortlist includes PeptideSwap, ZCash, 
Bitcoin, 
Morpho, Near Protocol and 
Monero, treating the projects as notable digital assets rather than centering the report on one presale. This produces a materially different set from CaptainAltcoin’s coverage: Morpho, Bitcoin and Monero appear across the supplied market context, while ZCash and Near Protocol appear only in Brave New Coin’s selection.
The coverage therefore overlaps on the prominence of PEPS but differs in scope and emphasis. CaptainAltcoin provides the most detail about the product launch, presale and peptide-sector opportunity; Brave New Coin emphasizes a diversified shortlist without supplying comparable figures for the other projects. DeFiLlama’s live data separately show Morpho’s total value locked at $11.04B, up 3.9% over seven days.
Live market conditions were broadly weak as the feature was published. Bitcoin traded at $75,555, down 6.00% over 24 hours and 3.82% over seven days, with a $1.52T market capitalization. Monero stood at $616.93, down 2.85% over 24 hours but up 4.35% over seven days, while Morpho was priced at $2.12, down 5.74% over 24 hours and up 1.77% over seven days.
The total crypto market capitalization was $2.61T, with the broader market broadly lower and the Fear & Greed index at 28, indicating fear. In that backdrop, the central development to monitor is PeptideSwap’s alpha marketplace and presale activity, while differing outlet selections provide context for how individual projects were being presented rather than a uniform consensus across the sector.
Since this brief published about 3 hours ago, Bitcoin (BTC) has moved from ₹71,42,745.38$75,555.00 to ₹71,90,959.26$76,065.00 — +0.68%.
The chart plots BTC's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
Will Bitcoin dip to $75,000 in November?
Crowd-implied probability on Polymarket, ₹18.65M 24h volume, resolves Dec 1 — snapshotted when this brief published (Nov 6 08:05 UTC). A market price reflects what traders collectively expect; it is not a forecast by Token Times and will have moved since. View the market ↗
At today's peer-to-peer rate, 1 BTC ≈ ₹7.91M (about $76,065.00), down 5.3% over 24 hours. The rupee itself trades about 10.0% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the assets in this story — live, source-stamped, updated every 15 minutes.
Figures and sectors in this story, checked live against on-chain aggregators · November 6, 2026.
Token Times reads these figures directly from on-chain aggregators (DeFiLlama, mempool.space) at build time — independent of what any outlet reported. Sector totals aggregate every protocol DeFiLlama tracks in that category. Values are live and will change.
PEPS Presale Leads a Differing Shortlist of November Crypto — questions & answers
What has PeptideSwap launched?
CaptainAltcoin reports that PeptideSwap launched an alpha version of a crypto-friendly marketplace intended for the peptide industry. The same outlet says a presale is live through its official website.
Which assets appear in both outlet selections?
The supplied coverage clearly identifies PeptideSwap, Bitcoin and Morpho as shared selections. The wider lists differ, with Brave New Coin also including ZCash, Near Protocol and Monero.
How are Morpho and Bitcoin performing now?
Morpho is at $2.12, down 5.74% over 24 hours, with $11.04B in TVL. Bitcoin is at $75,555, down 6.00% over 24 hours.
How much is 1 Bitcoin worth in rupee today?
About ₹7.91M at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $76,065.00. The rupee price moves with both BTC's US-dollar price and the USDT/INR rate; use our Bitcoin in rupee page for any amount.
Has Bitcoin's price moved since this brief was published?
BTC is up 0.68% since this brief first published — trading at ₹71,90,959 ($76,065.00) now versus ₹71,42,745 ($75,555.00) at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from CaptainAltcoin. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.